145 related articles for article (PubMed ID: 36560959)
1. Nivolumab for malignant transformation of ovarian mature cystic teratoma.
Yoshimura K; Yamanoi K; Kanai M; Okunomiya A; Sagae Y; Sunada M; Taki M; Ukita M; Chigusa Y; Horie A; Yamaguchi K; Hamanishi J; Minamiguchi S; Yamamoto N; Muto M; Mandai M
Gynecol Oncol Rep; 2022 Dec; 44():101115. PubMed ID: 36560959
[TBL] [Abstract][Full Text] [Related]
2. Squamous cell carcinoma in mature cystic teratoma of the ovary induced by human papillomavirus 16 infection: A case report and literature review.
Shi Z; Yang L; Bian C
Medicine (Baltimore); 2022 Sep; 101(38):e30667. PubMed ID: 36197169
[TBL] [Abstract][Full Text] [Related]
3. Malignant transformation in mature cystic teratoma of the ovary: a retrospective study of eight cases and review of literature.
Rathore R; Sharma S; Agarwal S
Prz Menopauzalny; 2018 Jun; 17(2):63-68. PubMed ID: 30150913
[TBL] [Abstract][Full Text] [Related]
4. Large cell neuroendocrine carcinoma arising in mature cystic teratoma: a case report and review of the literature.
Miyamoto M; Takano M; Goto T; Kato M; Sasaki N; Furuya K
Eur J Gynaecol Oncol; 2012; 33(4):414-8. PubMed ID: 23091901
[TBL] [Abstract][Full Text] [Related]
5. 30-Year Experience With 22 Cases of Malignant Transformation Arising From Ovarian Mature Cystic Teratoma: A Rare Disease.
Li Y; Qin M; Shan Y; Wu HW; Liu XD; Yin J; Gu Y; Wang W; Wang YX; Chen JY; Ma L; Jin Y; Pan LY
Front Oncol; 2022; 12():842703. PubMed ID: 35615156
[TBL] [Abstract][Full Text] [Related]
6. [Clinical analysis of 44 cases with malignant transformation of ovarian mature cystic teratoma].
An JS; Wu LY; Li XG; Zhang R; Song Y; Ma SK; Liu LY; Hong WJ
Zhonghua Fu Chan Ke Za Zhi; 2013 Feb; 48(2):123-8. PubMed ID: 23544494
[TBL] [Abstract][Full Text] [Related]
7. Immune checkpoint inhibitors of CTLA4 and PD-1 for malignant melanoma arising in ovarian cystic teratoma: A case report.
Yano M; Asami Y; Nishikawa T; Yoshida S; Kamada K; Katoh T; Teramoto Y; Nakamura Y; Yasuda M
Medicine (Baltimore); 2018 Oct; 97(43):e12937. PubMed ID: 30412106
[TBL] [Abstract][Full Text] [Related]
8. Malignant transformation arising from mature cystic teratoma of the ovary presenting as ovarian torsion: a case report and literature review.
Toba N; Takahashi T; Ota K; Takanashi A; Iizawa Y; Endo Y; Furukawa S; Soeda S; Watanabe T; Mizunuma H; Fujimori K; Takeichi K
Fukushima J Med Sci; 2020 Apr; 66(1):44-52. PubMed ID: 32161199
[TBL] [Abstract][Full Text] [Related]
9. Squamous cell carcinoma arising from a mature cystic teratoma of the ovary: Successful treatment with carboplatin, paclitaxel, and bevacizumab.
Fukase M; Ohta T; Watanabe N; Suzuki Y; Seino M; Sudo T; Nagase S
Gynecol Oncol Rep; 2020 Nov; 34():100632. PubMed ID: 32964091
[TBL] [Abstract][Full Text] [Related]
10. Malignant transformation arising from mature cystic teratoma of the ovary: a retrospective study of 20 cases.
Sakuma M; Otsuki T; Yoshinaga K; Utsunomiya H; Nagase S; Takano T; Niikura H; Ito K; Otomo K; Tase T; Watanabe Y; Yaegashi N
Int J Gynecol Cancer; 2010 Jul; 20(5):766-71. PubMed ID: 20973266
[TBL] [Abstract][Full Text] [Related]
11. Malignant transformation of ovarian mature cystic teratoma into squamous cell carcinoma: a Taiwanese Gynecologic Oncology Group (TGOG) study.
Chiang AJ; Chen MY; Weng CS; Lin H; Lu CH; Wang PH; Huang YF; Chiang YC; Yu MH; Chang CL
J Gynecol Oncol; 2017 Sep; 28(5):e69. PubMed ID: 28657230
[TBL] [Abstract][Full Text] [Related]
12. Malignant transformation arising from mature cystic teratoma of the ovary: a report of six cases.
Ulker V; Numanoglu C; Akbayir O; Akyol A; Tuncel A; Akca A; Aydin O
J Obstet Gynaecol Res; 2012 May; 38(5):849-53. PubMed ID: 22448642
[TBL] [Abstract][Full Text] [Related]
13. Malignant transformation of mature cystic teratoma of the ovary: experience at a single institution.
Park JY; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
Eur J Obstet Gynecol Reprod Biol; 2008 Dec; 141(2):173-8. PubMed ID: 18823690
[TBL] [Abstract][Full Text] [Related]
14. Malignant transformation from mature cystic teratoma of the ovary.
Shimada T; Higashijima A; Fukushima A; Komatsu N; Noguchi M; Ohashi K; Hasegawa Y; Miura K
J Obstet Gynaecol Res; 2019 Sep; 45(9):1957-1960. PubMed ID: 31215124
[TBL] [Abstract][Full Text] [Related]
15. Carbon ion radiotherapy for recurrent malignant transformation from mature cystic teratoma of the ovary.
Ito Y; Morikawa S; Kato S; Kajiyama H; Nawa A; Kikkawa F
J Obstet Gynaecol Res; 2012 May; 38(5):880-3. PubMed ID: 22449402
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and treatment outcomes of patients with malignant transformation arising from mature cystic teratoma of the ovary: experience at a single institution.
Oranratanaphan S; Khemapech N
Asian Pac J Cancer Prev; 2013; 14(8):4693-7. PubMed ID: 24083728
[TBL] [Abstract][Full Text] [Related]
17. Malignant transformation of ovarian teratoma responded well to immunotherapy after failed chemotherapy: a case report.
Li X; Tang X; Zhuo W
Ann Palliat Med; 2021 Jul; 10(7):8499-8505. PubMed ID: 34154338
[TBL] [Abstract][Full Text] [Related]
18. Poor prognosis of intraoperative rupture of mature cystic teratoma with malignant transformation.
Wen KC; Hu WM; Twu NF; Chen P; Wang PH
Taiwan J Obstet Gynecol; 2006 Sep; 45(3):253-6. PubMed ID: 17175475
[TBL] [Abstract][Full Text] [Related]
19. Experience of applying cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for ovarian teratoma with malignant transformation and peritoneal dissemination.
Yu HH; Yonemura Y; Hsieh MC; Lu CY; Wu SY; Shan YS
Ther Clin Risk Manag; 2019; 15():129-136. PubMed ID: 30679911
[TBL] [Abstract][Full Text] [Related]
20. Malignant transformation of ovarian mature cystic teratoma.
Rim SY; Kim SM; Choi HS
Int J Gynecol Cancer; 2006; 16(1):140-4. PubMed ID: 16445624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
